These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neuromuscular blocking agents: enhancing safety by reducing the risk of accidental administration. Koczmara C; Jelincic V Dynamics; 2007; 18(1):28-32. PubMed ID: 17396480 [TBL] [Abstract][Full Text] [Related]
3. Nursing care of patients receiving long-term infusion of neuromuscular blocking agents. Jarpe MB Crit Care Nurse; 1992 Oct; 12(7):58-63. PubMed ID: 1478105 [No Abstract] [Full Text] [Related]
4. Apnea after reversal of neuromuscular blockade. A case of rare mix-up. Ansari MM; Magaji GK; Abraham A Saudi Med J; 2007 Apr; 28(4):641-2. PubMed ID: 17457497 [No Abstract] [Full Text] [Related]
5. Neuromuscular blockers: administer with care. Cohen MR Nursing; 1989 Apr; 19(4):20. PubMed ID: 2717075 [No Abstract] [Full Text] [Related]
6. Drug related critical incidents. Khan FA; Hoda MQ Anaesthesia; 2005 Jan; 60(1):48-52. PubMed ID: 15601272 [TBL] [Abstract][Full Text] [Related]
7. Nerve stimulation in the setting of pharmacologic blockade. Villars PS Crit Care Nurse; 2008 Oct; 28(5):24; author reply 24. PubMed ID: 18827084 [No Abstract] [Full Text] [Related]
8. The danger with neuromuscular blocking agents. Paparella S J Emerg Nurs; 2004 Jun; 30(3):250-2. PubMed ID: 15192680 [No Abstract] [Full Text] [Related]
9. Adverse responses: sedation, analgesia and neuromuscular blocking agents in critically ill children. Sorce LR Crit Care Nurs Clin North Am; 2005 Dec; 17(4):441-50, xi-xii. PubMed ID: 16344213 [TBL] [Abstract][Full Text] [Related]
12. Train-of-four results and observed muscle movement in children during continuous neuromuscular blockade. Corso L Crit Care Nurse; 2008 Jun; 28(3):30-8; quiz 39. PubMed ID: 18515606 [No Abstract] [Full Text] [Related]
13. Have we learned how to relax our patients, by thinking outside the box? Lee C; Katz RL J Crit Care; 2009 Mar; 24(1):1-4. PubMed ID: 19272532 [No Abstract] [Full Text] [Related]
14. Persistent paralysis in critically ill patients after the use of neuromuscular blocking agents. Hoyt JW New Horiz; 1994 Feb; 2(1):48-55. PubMed ID: 7922429 [TBL] [Abstract][Full Text] [Related]
15. A national survey of critical care nurses' practices related to administration of neuromuscular blocking agents. Foster JG; Kish SK; Keenan CH Am J Crit Care; 2001 May; 10(3):139-45. PubMed ID: 11340735 [TBL] [Abstract][Full Text] [Related]
16. Nursing care of patients receiving long-term infusion of neuromuscular blocking agents. Day MW Crit Care Nurse; 1993 Feb; 13(1):19, 106. PubMed ID: 8481206 [No Abstract] [Full Text] [Related]
17. Neuromuscular blocking agents in critical care. Susla GM Crit Care Nurs Clin North Am; 1993 Jun; 5(2):297-311. PubMed ID: 8398037 [TBL] [Abstract][Full Text] [Related]
18. Pharmacology, selection and complications associated with neuromuscular blocking drugs in ICU patients. Prielipp RC Yale J Biol Med; 1998; 71(6):469-84. PubMed ID: 10604780 [No Abstract] [Full Text] [Related]
19. Neuromuscular blocking agents in the intensive care unit: a two-edged sword. Khuenl-Brady KS; Sparr HJ; Waibel U Crit Care Med; 1996 Apr; 24(4):717-9. PubMed ID: 8612428 [No Abstract] [Full Text] [Related]
20. [Acute myopathy related to the administration of glucocorticoids and neuromuscular blockers]. Miró O; Grau JM; Nadal P; Picado C; Plaza V; Urbano-Márquez A Med Clin (Barc); 1994 Oct; 103(12):458-60. PubMed ID: 7996895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]